Watanabe M - Search Results

1

Vesnarinone causes oxidative damage by inhibiting catalase function through ceramide action in myeloid cell apoptosis.

Kondo T, Suzuki Y, Kitano T, Iwai K, Watanabe M, Umehara H, Daido N, Domae N, Tashima M, Uchiyama T, Okazaki T. Kondo T, et al. Among authors: watanabe m. Mol Pharmacol. 2002 Mar;61(3):620-7. doi: 10.1124/mol.61.3.620. Mol Pharmacol. 2002. PMID: 11854443

2

Increase of ceramide in adriamycin-induced HL-60 cell apoptosis: detection by a novel anti-ceramide antibody.

Kawase M, Watanabe M, Kondo T, Yabu T, Taguchi Y, Umehara H, Uchiyama T, Mizuno K, Okazaki T. Kawase M, et al. Among authors: watanabe m. Biochim Biophys Acta. 2002 Oct 10;1584(2-3):104-14. doi: 10.1016/s1388-1981(02)00301-3. Biochim Biophys Acta. 2002. PMID: 12385893

3

Ceramide increases oxidative damage due to inhibition of catalase by caspase-3-dependent proteolysis in HL-60 cell apoptosis.

Iwai K, Kondo T, Watanabe M, Yabu T, Kitano T, Taguchi Y, Umehara H, Takahashi A, Uchiyama T, Okazaki T. Iwai K, et al. Among authors: watanabe m. J Biol Chem. 2003 Mar 14;278(11):9813-22. doi: 10.1074/jbc.M201867200. Epub 2003 Jan 2. J Biol Chem. 2003. PMID: 12511568 Free article.

4

Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.

Itoh M, Kitano T, Watanabe M, Kondo T, Yabu T, Taguchi Y, Iwai K, Tashima M, Uchiyama T, Okazaki T. Itoh M, et al. Among authors: watanabe m. Clin Cancer Res. 2003 Jan;9(1):415-23. Clin Cancer Res. 2003. PMID: 12538495

5

Increase of nuclear ceramide through caspase-3-dependent regulation of the "sphingomyelin cycle" in Fas-induced apoptosis.

Watanabe M, Kitano T, Kondo T, Yabu T, Taguchi Y, Tashima M, Umehara H, Domae N, Uchiyama T, Okazaki T. Watanabe M, et al. Cancer Res. 2004 Feb 1;64(3):1000-7. doi: 10.1158/0008-5472.can-03-1383. Cancer Res. 2004. PMID: 14871831

6

Interleukin-2-induced survival of natural killer (NK) cells involving phosphatidylinositol-3 kinase-dependent reduction of ceramide through acid sphingomyelinase, sphingomyelin synthase, and glucosylceramide synthase.

Taguchi Y, Kondo T, Watanabe M, Miyaji M, Umehara H, Kozutsumi Y, Okazaki T. Taguchi Y, et al. Among authors: watanabe m. Blood. 2004 Nov 15;104(10):3285-93. doi: 10.1182/blood-2004-03-0900. Epub 2004 Jul 22. Blood. 2004. PMID: 15271800 Free article.

7

Impact of Donor Source on Allogeneic Hematopoietic Stem Cell Transplantation for Mature T Cell and Natural Killer Cell Neoplasms in the Kyoto Stem Cell Transplantation Group.

Watanabe M, Kanda J, Arai Y, Hishizawa M, Nishikori M, Ishikawa T, Imada K, Ueda Y, Akasaka T, Yonezawa A, Nohgawa M, Kitano T, Itoh M, Takeoka T, Moriguchi T, Yago K, Arima N, Anzai N, Watanabe M, Kondo T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Watanabe M, et al. Biol Blood Marrow Transplant. 2020 Dec;26(12):2346-2358. doi: 10.1016/j.bbmt.2020.07.032. Epub 2020 Jul 30. Biol Blood Marrow Transplant. 2020. PMID: 32738500 Free article.

8

Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation.

Wada F, Nishikori M, Hishizawa M, Watanabe M, Aiba A, Kitano T, Shimazu Y, Shindo T, Kondo T, Takaori-Kondo A. Wada F, et al. Among authors: watanabe m. Int J Hematol. 2020 Nov;112(5):609-613. doi: 10.1007/s12185-020-03007-4. Epub 2020 Sep 26. Int J Hematol. 2020. PMID: 32980953

9

Establishment of a predictive model for GVHD-free, relapse-free survival after allogeneic HSCT using ensemble learning.

Iwasaki M, Kanda J, Arai Y, Kondo T, Ishikawa T, Ueda Y, Imada K, Akasaka T, Yonezawa A, Yago K, Nohgawa M, Anzai N, Moriguchi T, Kitano T, Itoh M, Arima N, Takeoka T, Watanabe M, Hirata H, Asagoe K, Miyatsuka I, An LM, Miyanishi M, Takaori-Kondo A. Iwasaki M, et al. Among authors: watanabe m. Blood Adv. 2022 Apr 26;6(8):2618-2627. doi: 10.1182/bloodadvances.2021005800. Blood Adv. 2022. PMID: 34933327 Free PMC article.

10

Single Cord Blood Transplantation Versus HLA-Haploidentical-related Donor Transplantation Using Posttransplant Cyclophosphamide in Patients With Hematological Malignancies.

Wada F, Kanda J, Yoshioka S, Ishikawa T, Akasaka T, Ueda Y, Hirata H, Arai Y, Yago K, Anzai N, Watanabe M, Ikeda T, Yonezawa A, Imada K, Itoh M, Kitano T, Takeoka T, Hishizawa M, Nohgawa M, Arima N, Asagoe K, Kondo T, Takaori-Kondo A; Kyoto Stem Cell Transplantation Group (KSCTG). Wada F, et al. Among authors: watanabe m. Transplantation. 2022 Jun 1;106(6):1279-1287. doi: 10.1097/TP.0000000000004006. Epub 2022 Dec 20. Transplantation. 2022. PMID: 34935764 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,232 results

Search Page

Filters